Edouard C. Nice

Active 1981–2025

150
Papers
19,451
Citations
84
h-index
146
i10-index

Citations

Citations per year for Edouard C. Nice1982: 1 citations1983: 3 citations1984: 4 citations1985: 2 citations1986: 6 citations1987: 11 citations1988: 24 citations1989: 14 citations1990: 21 citations1991: 21 citations1992: 23 citations1993: 13 citations1994: 25 citations1995: 32 citations1996: 27 citations1997: 40 citations1998: 34 citations1999: 41 citations2000: 53 citations2001: 65 citations2002: 103 citations2003: 138 citations2004: 133 citations2005: 121 citations2006: 122 citations2007: 124 citations2008: 147 citations2009: 111 citations2010: 90 citations2011: 111 citations2012: 75 citations2013: 87 citations2014: 124 citations2015: 104 citations2016: 101 citations2017: 108 citations2018: 106 citations2019: 367 citations2020: 415 citations2021: 591 citations2022: 641 citations2023: 687 citations2024: 1,306 citations2025: 789 citations2026: 36 citations

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,159 citing papers, 23.1% of this breakdownUnited States: 1,820 citing papers, 19.5% of this breakdownAustralia: 496 citing papers, 5.3% of this breakdownGermany: 374 citing papers, 4% of this breakdownUnited Kingdom: 355 citing papers, 3.8% of this breakdownIndia: 308 citing papers, 3.3% of this breakdownItaly: 293 citing papers, 3.1% of this breakdownCanada: 248 citing papers, 2.7% of this breakdownJapan: 239 citing papers, 2.6% of this breakdownSouth Korea: 189 citing papers, 2% of this breakdownFrance: 176 citing papers, 1.9% of this breakdownSpain: 172 citing papers, 1.9% of this breakdown
0%23.1%Other 26.8%

Fields

  • Medicine42%
  • Biochemistry, Genetics and Molecular Biology34.6%
  • Immunology and Microbiology4.9%
  • Materials Science4.1%
  • Engineering3.6%
  • Chemistry3%
  • Other7.8%

Topics

  • HER2/EGFR in Cancer Research2.5%
  • Monoclonal and Polyclonal Antibodies Research2.4%
  • Lymphatic System and Diseases1.9%
  • Nanoplatforms for cancer theranostics1.9%
  • Autophagy in Disease and Therapy1.9%
  • Cancer, Hypoxia, and Metabolism1.9%
  • Other87.5%

Coauthors

All papers

Open in search
  1. Oral squamous cell carcinomas: state of the field and emerging directions

    Authors: , , , , , , , , - International Journal of Oral Science 2023 cited by 703

  2. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies

    Authors: , , , , , , , , , - Journal of Hematology & Oncology 2022 cited by 406

  3. Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A

    Authors: , , , , , - Molecular Oncology 2021 cited by 332

  4. Oxidative stress and diabetes: antioxidative strategies

    Authors: , , , , , - Frontiers of Medicine 2020 cited by 512

  5. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

    Authors: , , , , , , - Journal of Hematology & Oncology 2022 cited by 254

  6. Overcoming cancer therapeutic bottleneck by drug repurposing

    Authors: , , , , , , - Signal Transduction and Targeted Therapy 2020 cited by 507

  7. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA

    Authors: , , , , , , , , , , , , , - Molecular Cancer 2022 cited by 154

  8. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

    Authors: , , , , , , - Bone Research 2023 cited by 208

  9. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment

    Authors: , , , , , , - Frontiers in Cell and Developmental Biology 2021 cited by 211

  10. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , - Nature Communications 2023 cited by 122

  11. Antioxidant Therapy in Cancer: Rationale and Progress

    Authors: , , , , , , - Antioxidants 2022 cited by 183

  12. Emerging role of tumor cell plasticity in modifying therapeutic response

    Authors: , , , , , , - Signal Transduction and Targeted Therapy 2020 cited by 284

  13. Brain‐Targeted HFn‐Cu‐REGO Nanoplatform for Site‐Specific Delivery and Manipulation of Autophagy and Cuproptosis in Glioblastoma

    Authors: , , , , , , , , , - Small 2022 cited by 89

  14. Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies

    Authors: , , , , , , , - Cancers 2022 cited by 146

  15. Redox regulation: mechanisms, biology and therapeutic targets in diseases

    Authors: , , , , , , - Signal Transduction and Targeted Therapy 2025 cited by 225

  16. Circadian rhythms and cancers: the intrinsic links and therapeutic potentials

    Authors: , , , , , - Journal of Hematology & Oncology 2022 cited by 146

  17. Clinical Chemotherapeutic Agent Coordinated Copper‐Based Nanoadjuvants for Efficiently Sensitizing Cancer Chemo‐Immunotherapy by Cuproptosis‐Mediated Mitochondrial Metabolic Reprogramming

    Authors: , , , , , , , , - Advanced Functional Materials 2023 cited by 60

  18. Redox signaling at the crossroads of human health and disease

    Authors: , , , , , , , - MedComm 2022 cited by 112

  19. Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy

    Authors: , , , , , - Signal Transduction and Targeted Therapy 2017 cited by 224

  20. A high-stringency blueprint of the human proteome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sara A. Wennersten, Juan Antonio Vizcaíno, Marc R. Wilkins, Jochen M. Schwenk, Emma Lundberg, Nuno Bandeira, György Marko‐Varga, Susan T. Weintraub, Charles Pineau, Ulrike Kusebauch, Robert L. Moritz, Seong Beom Ahn, Magnus Palmblad, M Snyder, Ruedi Aebersold, Mark S. Baker - Nature Communications 2020 cited by 217

  21. Insights and implications of sexual dimorphism in osteoporosis

    Authors: , , , , , , , - Bone Research 2024 cited by 127

  22. Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , - ACS Applied Materials & Interfaces 2022 cited by 61

  23. Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Autophagy 2019 cited by 147

  24. Redox Regulation of Inflammation: Old Elements, a New Story

    Authors: , , , , , - Medicinal Research Reviews 2014 cited by 205